Women benefit as much as men from secondary prevention effects of statins, despite lower representation in trials

September 2012
Menopause International;Sep2012, Vol. 18 Issue 3, p97
Academic Journal
The article offers information on the use of statins in women and states that the American Heart Association has recommended statin therapy in women for desired cholesterol targets to reduce the risks of cardiovascular events.


Related Articles

  • 2013 ACC/AHA Cholesterol Guideline Greatly Increases Number Eligible for Statin Treatment. HUGHES, LAUREN S.; EBELL, MARK H. // American Family Physician;8/15/2014, Vol. 90 Issue 4, p259C 

    The article discusses research concerning the 2013 cholesterol guideline issued by the American College of Cardiology (ACC) and American Heart Association (AHA), conducted by M. J. Pencina and colleagues, published in a 2014 issue of "New England Journal of Medicine." Topics explored include the...

  • INVESTIGATION OF LIPID LOWERING ACTIVITY OF GSK-3 INHIBITOR. Patel, Manish M.; Shah, Kirankumar K. // International Journal of Pharmaceutical Sciences Review & Resear;Nov2010, Vol. 5 Issue 1, p161 

    Cardiovascular diseases are the number one killer in the united state as well as developed western countries. According to estimates from the American Heart Association, about 80 millions of American people have one or more types of CVD. This is the condition despite of presence of many anti...

  • Contemporary Evidence-Based Guidelines: Practice Based on the Strongest Evidence. Robinson, Jennifer G. // Mayo Clinic Proceedings;Sep2014, Vol. 89 Issue 9, p1176 

    The author discusses guidelines issued in 2013 by the American College of Cardiology (ACC) and the American Heart Association (AHA) regarding the treatment of blood cholesterol to reduce atherosclerotic risk and the assessment of cardiovascular risk. Topics covered include recommendations for...

  • More Than a Billion People Taking Statins? Ioannidis, John P. A. // JAMA: Journal of the American Medical Association;2/5/2014, Vol. 311 Issue 5, p463 

    The author comments on the criticism of the American College of Cardiology/American Heart Association (ACC/AHA) guidelines on assessment of cardiovascular risk and on treatment of blood cholesterol, which included recommendations for primary prevention with statins. He states that the main...

  • Getting to the Heart of the Matter. Olivo, Lisa // Nutraceuticals World;Nov2015, Vol. 18 Issue 9, p40 

    Topics discussed include the Americans with cardiovascular disease (CVD) based on the data from the American Heart Association (AHA), statement from pharmaceutical company Proprietary Nutritionals Inc.'s president Dean Mosca regarding the aging population as the traditional consumers of...

  • Statinopause. Han, Benjamin; Weinberger, Yitzchak; Sutin, David // JGIM: Journal of General Internal Medicine;Dec2014, Vol. 29 Issue 12, p1702 

    Statins are the cornerstone of lipid-lowering therapy for cardiovascular disease prevention. The 2013 American College of Cardiology (ACC) and American Heart Association (AHA) guidelines represent a fundamental shift in how statins will be prescribed. The new guidelines recommend statins for...

  • Newer cholesterol guidelines better at identifying increased risk of CVD events.  // Clinical Advisor;Sep2015, Vol. 18 Issue 9, p27 

    No abstract available.

  • Lipid Guidelines Update. MIKOLAI, JEREMY // Naturopathic Doctor News & Review;Oct2014, Vol. 10 Issue 10, p1 

    The article discusses the November 2013 update to American practice guidelines on lipid management for the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD) in adults issued by the American College of Cardiology and American Heart Association (ACC/AHA). Topics include...

  • Lipid care: Data favor new guidelines, novel therapy may be future option. TANZI, MARIA G. // Pharmacy Today;Oct2014, Vol. 20 Issue 10, p30 

    The article focuses on the guidelines on lipid care released by the American Heart Association (AHA) and American College of Cardiology (ACC). The use of statins for patients who are at higher risk for cardiovascular events is recommended. The potential of a self-injected lipid-lowering agent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics